Nutex Health Schedules 2025 First Quarter Financial Results Release and Conference Call
Rhea-AI Summary
Nutex Health (NASDAQ: NUTX), a physician-led healthcare delivery system operating 24 micro hospitals across 11 states, has announced its schedule for the release of Q1 2025 financial results. The company will release its financial results for the quarter ended March 31, 2025, after market close on Tuesday, May 13, 2025.
A conference call to discuss the results is scheduled for Wednesday, May 14, 2025, at 10:30 a.m. ET. Participants can join via phone (1-877-407-9208 or 1-201-493-6784) or through a dedicated online link. For those unable to attend live, a recording will be available on the company's website.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, NUTX declined 11.62%, reflecting a significant negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Participant Listening: 1-877-407-9208 or 1-201-493-6784
Participant Link: https://callme.viavid.com/viavid/?callme=true&passcode=13746493&h=true&info=company&r=true&B=6
To access the call, please dial in approximately five minutes before start time. Those who are unable to attend the live conference call may access the recording on the Company's website.
About Nutex Health Inc.
Headquartered in
The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups.
Forward-Looking Statements
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended year ended December 31, 2024 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.
View original content:https://www.prnewswire.com/news-releases/nutex-health-schedules-2025-first-quarter-financial-results-release-and-conference-call-302448272.html
SOURCE Nutex Health, Inc.